Table 2 Ablative versus RIC allotherapy... | American Society of Hematology

Table 2

Ablative versus RIC allotherapy in MDS/AML patients more than 50 years of age

	Relapse, %	TRM, %
Ablative	38	37
RIC	56	24

Adapted from Alyea et al²⁵ with permission.

TRM indicates transplantation-related mortality.